10x Genomics Blog December 2, 2025 Morgan Stanley Downgrades 10x Genomics to Equalweight From Overweight, Lifts Price Target to $20 From $17 - MarketScreener This article's full content could not be retrieved due to source site restrictions. Read full story on 10x Genomics Blog